COMMUNIQUÉS West-GlobeNewswire
-
NKGen Biotech to Present Troculeucel Mechanism Data in Alzheimer’s and Frontotemporal Dementia at the Neuroimmunology Drug Development Summit
09/04/2026 -
BCAN Names Ferring Pharmaceuticals and the Astellas/Pfizer Alliance as National Presenting Sponsors of the 2026 Walks to End Bladder Cancer
09/04/2026 -
Over 60 Million Showed They Are #MoreThanMyeloma During 2026 Myeloma Action Month
09/04/2026 -
Boehringer Ingelheim to evaluate innovative combination of DLL3‑targeting T‑cell engager plus PD‑L1/VEGF‑A bispecific antibody in small cell lung cancer
09/04/2026 -
Immix Biopharma to Participate in the Jefferies Global Healthcare Conference
09/04/2026 -
The Growing Connection Between Microplastics and the Human Heart
09/04/2026 -
Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
09/04/2026 -
Cardiology Consultants of Philadelphia Launches CCP Now, a Specialized Cardiac Walk-In Facility in Delaware County
09/04/2026 -
Myriad Genetics Underscores Commitment to Cancer Care Continuum with New Data Presentations at SGO Annual Meeting
09/04/2026 -
Tria Federal Earns Prestigious 2026 USA TODAY Top Workplaces Award
09/04/2026 -
Kestra Medical Technologies Named a 2026 USA TODAY Top Workplaces Award Winner
09/04/2026 -
Sparian Biosciences Announces Initiation of Phase 1 Clinical Trial of SBS-147 Next Generation Arylepoxamide Agonist for the Treatment of Pain Funded by a $15M NIH Grant
09/04/2026 -
Global Alzheimer’s Platform Foundation Announces Strategic Collaboration and Partnership with Siemens Healthineers for the Transformative Bio-Hermes-002 Study
09/04/2026 -
Annovis Announces $10 Million Underwritten Offering of Common Stock and Accompanying Warrants
09/04/2026 -
Imprivata Appoints Cindy Zhou as Chief Marketing Officer
09/04/2026 -
Weight Watchers Launches Eli Lilly and Company’s New Oral GLP-1 Foundayo® Available Through LillyDirect
09/04/2026 -
Kyverna Therapeutics to Host Conference Call on New Data Across Neuroimmunology Franchise at AAN 2026
09/04/2026 -
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026
09/04/2026 -
Cures Within Reach Approves Five Clinical Trials at Chicago-based Research Institutions
09/04/2026
Pages